Pharma & Healthcare
Global Lacosamide Drugs Market Research Report 2024
- Sep 18, 24
- ID: 553591
- Pages: 104
- Figures: 103
- Views: 1
Lacosamide is an anticonvulsant medication used to manage certain types of seizures in epilepsy.Lacosamide works by stabilizing hyperexcitable neuronal membranes and modulating the activity of sodium channels, which helps to prevent the excessive electrical activity in the brain that leads to seizures. It is typically taken in the form of tablets or oral solution.
The global Lacosamide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Lacosamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lacosamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lacosamide Drugs include UCB Pharma, Glenmark Pharmaceuticals, Camber Pharma, Actavis, Sandoz, Teva, Apotex, Mylan, Sun Pharma, Aucta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lacosamide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacosamide Drugs.
The Lacosamide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Lacosamide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lacosamide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
UCB Pharma
Glenmark Pharmaceuticals
Camber Pharma
Actavis
Sandoz
Teva
Apotex
Mylan
Sun Pharma
Aucta Pharma
Hefei Yifan Biopharmaceuticals
Jiangsu Haian Pharmaceutical
CSPC Ouyi Pharmaceutical
Shijiazhuang No.4 Pharmaceutical
Shandong Loncom Pharmaceutical
Jianmin Group
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Zhejiang Huahai Pharmaceutical
Buchang Pharmaceutical
Segment by Type
Tablets
Injection
Oral Solution
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lacosamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lacosamide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Lacosamide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Lacosamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lacosamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lacosamide Drugs include UCB Pharma, Glenmark Pharmaceuticals, Camber Pharma, Actavis, Sandoz, Teva, Apotex, Mylan, Sun Pharma, Aucta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lacosamide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacosamide Drugs.
The Lacosamide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Lacosamide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lacosamide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
UCB Pharma
Glenmark Pharmaceuticals
Camber Pharma
Actavis
Sandoz
Teva
Apotex
Mylan
Sun Pharma
Aucta Pharma
Hefei Yifan Biopharmaceuticals
Jiangsu Haian Pharmaceutical
CSPC Ouyi Pharmaceutical
Shijiazhuang No.4 Pharmaceutical
Shandong Loncom Pharmaceutical
Jianmin Group
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Zhejiang Huahai Pharmaceutical
Buchang Pharmaceutical
Segment by Type
Tablets
Injection
Oral Solution
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lacosamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lacosamide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Lacosamide Drugs Market Overview
1.1 Product Definition
1.2 Lacosamide Drugs by Type
1.2.1 Global Lacosamide Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Injection
1.2.4 Oral Solution
1.3 Lacosamide Drugs by Application
1.3.1 Global Lacosamide Drugs Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Lacosamide Drugs Market Size Estimates and Forecasts
1.4.1 Global Lacosamide Drugs Revenue 2019-2030
1.4.2 Global Lacosamide Drugs Sales 2019-2030
1.4.3 Global Lacosamide Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lacosamide Drugs Market Competition by Manufacturers
2.1 Global Lacosamide Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lacosamide Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lacosamide Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Lacosamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lacosamide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lacosamide Drugs, Product Type & Application
2.7 Global Key Manufacturers of Lacosamide Drugs, Date of Enter into This Industry
2.8 Global Lacosamide Drugs Market Competitive Situation and Trends
2.8.1 Global Lacosamide Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lacosamide Drugs Players Market Share by Revenue
2.8.3 Global Lacosamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lacosamide Drugs Market Scenario by Region
3.1 Global Lacosamide Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lacosamide Drugs Sales by Region: 2019-2030
3.2.1 Global Lacosamide Drugs Sales by Region: 2019-2024
3.2.2 Global Lacosamide Drugs Sales by Region: 2025-2030
3.3 Global Lacosamide Drugs Revenue by Region: 2019-2030
3.3.1 Global Lacosamide Drugs Revenue by Region: 2019-2024
3.3.2 Global Lacosamide Drugs Revenue by Region: 2025-2030
3.4 North America Lacosamide Drugs Market Facts & Figures by Country
3.4.1 North America Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lacosamide Drugs Sales by Country (2019-2030)
3.4.3 North America Lacosamide Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lacosamide Drugs Market Facts & Figures by Country
3.5.1 Europe Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lacosamide Drugs Sales by Country (2019-2030)
3.5.3 Europe Lacosamide Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lacosamide Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Lacosamide Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lacosamide Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Lacosamide Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lacosamide Drugs Market Facts & Figures by Country
3.7.1 Latin America Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lacosamide Drugs Sales by Country (2019-2030)
3.7.3 Latin America Lacosamide Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lacosamide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lacosamide Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lacosamide Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lacosamide Drugs Sales by Type (2019-2030)
4.1.1 Global Lacosamide Drugs Sales by Type (2019-2024)
4.1.2 Global Lacosamide Drugs Sales by Type (2025-2030)
4.1.3 Global Lacosamide Drugs Sales Market Share by Type (2019-2030)
4.2 Global Lacosamide Drugs Revenue by Type (2019-2030)
4.2.1 Global Lacosamide Drugs Revenue by Type (2019-2024)
4.2.2 Global Lacosamide Drugs Revenue by Type (2025-2030)
4.2.3 Global Lacosamide Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Lacosamide Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lacosamide Drugs Sales by Application (2019-2030)
5.1.1 Global Lacosamide Drugs Sales by Application (2019-2024)
5.1.2 Global Lacosamide Drugs Sales by Application (2025-2030)
5.1.3 Global Lacosamide Drugs Sales Market Share by Application (2019-2030)
5.2 Global Lacosamide Drugs Revenue by Application (2019-2030)
5.2.1 Global Lacosamide Drugs Revenue by Application (2019-2024)
5.2.2 Global Lacosamide Drugs Revenue by Application (2025-2030)
5.2.3 Global Lacosamide Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Lacosamide Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 UCB Pharma
6.1.1 UCB Pharma Company Information
6.1.2 UCB Pharma Description and Business Overview
6.1.3 UCB Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 UCB Pharma Lacosamide Drugs Product Portfolio
6.1.5 UCB Pharma Recent Developments/Updates
6.2 Glenmark Pharmaceuticals
6.2.1 Glenmark Pharmaceuticals Company Information
6.2.2 Glenmark Pharmaceuticals Description and Business Overview
6.2.3 Glenmark Pharmaceuticals Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio
6.2.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.3 Camber Pharma
6.3.1 Camber Pharma Company Information
6.3.2 Camber Pharma Description and Business Overview
6.3.3 Camber Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Camber Pharma Lacosamide Drugs Product Portfolio
6.3.5 Camber Pharma Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Company Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actavis Lacosamide Drugs Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz Lacosamide Drugs Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Lacosamide Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Apotex Lacosamide Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Lacosamide Drugs Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Company Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharma Lacosamide Drugs Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Aucta Pharma
6.10.1 Aucta Pharma Company Information
6.10.2 Aucta Pharma Description and Business Overview
6.10.3 Aucta Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aucta Pharma Lacosamide Drugs Product Portfolio
6.10.5 Aucta Pharma Recent Developments/Updates
6.11 Hefei Yifan Biopharmaceuticals
6.11.1 Hefei Yifan Biopharmaceuticals Company Information
6.11.2 Hefei Yifan Biopharmaceuticals Description and Business Overview
6.11.3 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio
6.11.5 Hefei Yifan Biopharmaceuticals Recent Developments/Updates
6.12 Jiangsu Haian Pharmaceutical
6.12.1 Jiangsu Haian Pharmaceutical Company Information
6.12.2 Jiangsu Haian Pharmaceutical Description and Business Overview
6.12.3 Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio
6.12.5 Jiangsu Haian Pharmaceutical Recent Developments/Updates
6.13 CSPC Ouyi Pharmaceutical
6.13.1 CSPC Ouyi Pharmaceutical Company Information
6.13.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.13.3 CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio
6.13.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.14 Shijiazhuang No.4 Pharmaceutical
6.14.1 Shijiazhuang No.4 Pharmaceutical Company Information
6.14.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
6.14.3 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio
6.14.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.15 Shandong Loncom Pharmaceutical
6.15.1 Shandong Loncom Pharmaceutical Company Information
6.15.2 Shandong Loncom Pharmaceutical Description and Business Overview
6.15.3 Shandong Loncom Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio
6.15.5 Shandong Loncom Pharmaceutical Recent Developments/Updates
6.16 Jianmin Group
6.16.1 Jianmin Group Company Information
6.16.2 Jianmin Group Description and Business Overview
6.16.3 Jianmin Group Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jianmin Group Lacosamide Drugs Product Portfolio
6.16.5 Jianmin Group Recent Developments/Updates
6.17 Jiangxi Qingfeng Pharmaceutical
6.17.1 Jiangxi Qingfeng Pharmaceutical Company Information
6.17.2 Jiangxi Qingfeng Pharmaceutical Description and Business Overview
6.17.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio
6.17.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
6.18 Beijing Sihuan Pharmaceutical
6.18.1 Beijing Sihuan Pharmaceutical Company Information
6.18.2 Beijing Sihuan Pharmaceutical Description and Business Overview
6.18.3 Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio
6.18.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
6.19 Zhejiang Huahai Pharmaceutical
6.19.1 Zhejiang Huahai Pharmaceutical Company Information
6.19.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.19.3 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio
6.19.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.20 Buchang Pharmaceutical
6.20.1 Buchang Pharmaceutical Company Information
6.20.2 Buchang Pharmaceutical Description and Business Overview
6.20.3 Buchang Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Buchang Pharmaceutical Lacosamide Drugs Product Portfolio
6.20.5 Buchang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lacosamide Drugs Industry Chain Analysis
7.2 Lacosamide Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lacosamide Drugs Production Mode & Process
7.4 Lacosamide Drugs Sales and Marketing
7.4.1 Lacosamide Drugs Sales Channels
7.4.2 Lacosamide Drugs Distributors
7.5 Lacosamide Drugs Customers
8 Lacosamide Drugs Market Dynamics
8.1 Lacosamide Drugs Industry Trends
8.2 Lacosamide Drugs Market Drivers
8.3 Lacosamide Drugs Market Challenges
8.4 Lacosamide Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Lacosamide Drugs by Type
1.2.1 Global Lacosamide Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Injection
1.2.4 Oral Solution
1.3 Lacosamide Drugs by Application
1.3.1 Global Lacosamide Drugs Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Lacosamide Drugs Market Size Estimates and Forecasts
1.4.1 Global Lacosamide Drugs Revenue 2019-2030
1.4.2 Global Lacosamide Drugs Sales 2019-2030
1.4.3 Global Lacosamide Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lacosamide Drugs Market Competition by Manufacturers
2.1 Global Lacosamide Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lacosamide Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lacosamide Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Lacosamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lacosamide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lacosamide Drugs, Product Type & Application
2.7 Global Key Manufacturers of Lacosamide Drugs, Date of Enter into This Industry
2.8 Global Lacosamide Drugs Market Competitive Situation and Trends
2.8.1 Global Lacosamide Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lacosamide Drugs Players Market Share by Revenue
2.8.3 Global Lacosamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lacosamide Drugs Market Scenario by Region
3.1 Global Lacosamide Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lacosamide Drugs Sales by Region: 2019-2030
3.2.1 Global Lacosamide Drugs Sales by Region: 2019-2024
3.2.2 Global Lacosamide Drugs Sales by Region: 2025-2030
3.3 Global Lacosamide Drugs Revenue by Region: 2019-2030
3.3.1 Global Lacosamide Drugs Revenue by Region: 2019-2024
3.3.2 Global Lacosamide Drugs Revenue by Region: 2025-2030
3.4 North America Lacosamide Drugs Market Facts & Figures by Country
3.4.1 North America Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lacosamide Drugs Sales by Country (2019-2030)
3.4.3 North America Lacosamide Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lacosamide Drugs Market Facts & Figures by Country
3.5.1 Europe Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lacosamide Drugs Sales by Country (2019-2030)
3.5.3 Europe Lacosamide Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lacosamide Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Lacosamide Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lacosamide Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Lacosamide Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lacosamide Drugs Market Facts & Figures by Country
3.7.1 Latin America Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lacosamide Drugs Sales by Country (2019-2030)
3.7.3 Latin America Lacosamide Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lacosamide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Lacosamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lacosamide Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lacosamide Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lacosamide Drugs Sales by Type (2019-2030)
4.1.1 Global Lacosamide Drugs Sales by Type (2019-2024)
4.1.2 Global Lacosamide Drugs Sales by Type (2025-2030)
4.1.3 Global Lacosamide Drugs Sales Market Share by Type (2019-2030)
4.2 Global Lacosamide Drugs Revenue by Type (2019-2030)
4.2.1 Global Lacosamide Drugs Revenue by Type (2019-2024)
4.2.2 Global Lacosamide Drugs Revenue by Type (2025-2030)
4.2.3 Global Lacosamide Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Lacosamide Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lacosamide Drugs Sales by Application (2019-2030)
5.1.1 Global Lacosamide Drugs Sales by Application (2019-2024)
5.1.2 Global Lacosamide Drugs Sales by Application (2025-2030)
5.1.3 Global Lacosamide Drugs Sales Market Share by Application (2019-2030)
5.2 Global Lacosamide Drugs Revenue by Application (2019-2030)
5.2.1 Global Lacosamide Drugs Revenue by Application (2019-2024)
5.2.2 Global Lacosamide Drugs Revenue by Application (2025-2030)
5.2.3 Global Lacosamide Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Lacosamide Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 UCB Pharma
6.1.1 UCB Pharma Company Information
6.1.2 UCB Pharma Description and Business Overview
6.1.3 UCB Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 UCB Pharma Lacosamide Drugs Product Portfolio
6.1.5 UCB Pharma Recent Developments/Updates
6.2 Glenmark Pharmaceuticals
6.2.1 Glenmark Pharmaceuticals Company Information
6.2.2 Glenmark Pharmaceuticals Description and Business Overview
6.2.3 Glenmark Pharmaceuticals Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio
6.2.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.3 Camber Pharma
6.3.1 Camber Pharma Company Information
6.3.2 Camber Pharma Description and Business Overview
6.3.3 Camber Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Camber Pharma Lacosamide Drugs Product Portfolio
6.3.5 Camber Pharma Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Company Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Actavis Lacosamide Drugs Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz Lacosamide Drugs Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Lacosamide Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Apotex Lacosamide Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Lacosamide Drugs Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Company Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharma Lacosamide Drugs Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Aucta Pharma
6.10.1 Aucta Pharma Company Information
6.10.2 Aucta Pharma Description and Business Overview
6.10.3 Aucta Pharma Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aucta Pharma Lacosamide Drugs Product Portfolio
6.10.5 Aucta Pharma Recent Developments/Updates
6.11 Hefei Yifan Biopharmaceuticals
6.11.1 Hefei Yifan Biopharmaceuticals Company Information
6.11.2 Hefei Yifan Biopharmaceuticals Description and Business Overview
6.11.3 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio
6.11.5 Hefei Yifan Biopharmaceuticals Recent Developments/Updates
6.12 Jiangsu Haian Pharmaceutical
6.12.1 Jiangsu Haian Pharmaceutical Company Information
6.12.2 Jiangsu Haian Pharmaceutical Description and Business Overview
6.12.3 Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio
6.12.5 Jiangsu Haian Pharmaceutical Recent Developments/Updates
6.13 CSPC Ouyi Pharmaceutical
6.13.1 CSPC Ouyi Pharmaceutical Company Information
6.13.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.13.3 CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio
6.13.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.14 Shijiazhuang No.4 Pharmaceutical
6.14.1 Shijiazhuang No.4 Pharmaceutical Company Information
6.14.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
6.14.3 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio
6.14.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.15 Shandong Loncom Pharmaceutical
6.15.1 Shandong Loncom Pharmaceutical Company Information
6.15.2 Shandong Loncom Pharmaceutical Description and Business Overview
6.15.3 Shandong Loncom Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio
6.15.5 Shandong Loncom Pharmaceutical Recent Developments/Updates
6.16 Jianmin Group
6.16.1 Jianmin Group Company Information
6.16.2 Jianmin Group Description and Business Overview
6.16.3 Jianmin Group Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jianmin Group Lacosamide Drugs Product Portfolio
6.16.5 Jianmin Group Recent Developments/Updates
6.17 Jiangxi Qingfeng Pharmaceutical
6.17.1 Jiangxi Qingfeng Pharmaceutical Company Information
6.17.2 Jiangxi Qingfeng Pharmaceutical Description and Business Overview
6.17.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio
6.17.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
6.18 Beijing Sihuan Pharmaceutical
6.18.1 Beijing Sihuan Pharmaceutical Company Information
6.18.2 Beijing Sihuan Pharmaceutical Description and Business Overview
6.18.3 Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio
6.18.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
6.19 Zhejiang Huahai Pharmaceutical
6.19.1 Zhejiang Huahai Pharmaceutical Company Information
6.19.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.19.3 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio
6.19.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.20 Buchang Pharmaceutical
6.20.1 Buchang Pharmaceutical Company Information
6.20.2 Buchang Pharmaceutical Description and Business Overview
6.20.3 Buchang Pharmaceutical Lacosamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Buchang Pharmaceutical Lacosamide Drugs Product Portfolio
6.20.5 Buchang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lacosamide Drugs Industry Chain Analysis
7.2 Lacosamide Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lacosamide Drugs Production Mode & Process
7.4 Lacosamide Drugs Sales and Marketing
7.4.1 Lacosamide Drugs Sales Channels
7.4.2 Lacosamide Drugs Distributors
7.5 Lacosamide Drugs Customers
8 Lacosamide Drugs Market Dynamics
8.1 Lacosamide Drugs Industry Trends
8.2 Lacosamide Drugs Market Drivers
8.3 Lacosamide Drugs Market Challenges
8.4 Lacosamide Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Lacosamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lacosamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Lacosamide Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lacosamide Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Lacosamide Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lacosamide Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lacosamide Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lacosamide Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lacosamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lacosamide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lacosamide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Lacosamide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lacosamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lacosamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lacosamide Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Lacosamide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Lacosamide Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Lacosamide Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Lacosamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lacosamide Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Lacosamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lacosamide Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lacosamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lacosamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lacosamide Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lacosamide Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Lacosamide Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Lacosamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lacosamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lacosamide Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Lacosamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lacosamide Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Lacosamide Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Lacosamide Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Lacosamide Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Lacosamide Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lacosamide Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lacosamide Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Lacosamide Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Lacosamide Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Lacosamide Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Lacosamide Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Lacosamide Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Lacosamide Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Lacosamide Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Lacosamide Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lacosamide Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lacosamide Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Lacosamide Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Lacosamide Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Lacosamide Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. UCB Pharma Company Information
Table 71. UCB Pharma Description and Business Overview
Table 72. UCB Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. UCB Pharma Lacosamide Drugs Product
Table 74. UCB Pharma Recent Developments/Updates
Table 75. Glenmark Pharmaceuticals Company Information
Table 76. Glenmark Pharmaceuticals Description and Business Overview
Table 77. Glenmark Pharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Glenmark Pharmaceuticals Lacosamide Drugs Product
Table 79. Glenmark Pharmaceuticals Recent Developments/Updates
Table 80. Camber Pharma Company Information
Table 81. Camber Pharma Description and Business Overview
Table 82. Camber Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Camber Pharma Lacosamide Drugs Product
Table 84. Camber Pharma Recent Developments/Updates
Table 85. Actavis Company Information
Table 86. Actavis Description and Business Overview
Table 87. Actavis Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Actavis Lacosamide Drugs Product
Table 89. Actavis Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sandoz Lacosamide Drugs Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Teva Lacosamide Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Apotex Company Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Apotex Lacosamide Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Mylan Lacosamide Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. Sun Pharma Company Information
Table 111. Sun Pharma Description and Business Overview
Table 112. Sun Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Sun Pharma Lacosamide Drugs Product
Table 114. Sun Pharma Recent Developments/Updates
Table 115. Aucta Pharma Company Information
Table 116. Aucta Pharma Description and Business Overview
Table 117. Aucta Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Aucta Pharma Lacosamide Drugs Product
Table 119. Aucta Pharma Recent Developments/Updates
Table 120. Hefei Yifan Biopharmaceuticals Company Information
Table 121. Hefei Yifan Biopharmaceuticals Description and Business Overview
Table 122. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product
Table 124. Hefei Yifan Biopharmaceuticals Recent Developments/Updates
Table 125. Jiangsu Haian Pharmaceutical Company Information
Table 126. Jiangsu Haian Pharmaceutical Description and Business Overview
Table 127. Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Jiangsu Haian Pharmaceutical Lacosamide Drugs Product
Table 129. Jiangsu Haian Pharmaceutical Recent Developments/Updates
Table 130. CSPC Ouyi Pharmaceutical Company Information
Table 131. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 132. CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. CSPC Ouyi Pharmaceutical Lacosamide Drugs Product
Table 134. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 135. Shijiazhuang No.4 Pharmaceutical Company Information
Table 136. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
Table 137. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product
Table 139. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
Table 140. Shandong Loncom Pharmaceutical Company Information
Table 141. Shandong Loncom Pharmaceutical Description and Business Overview
Table 142. Shandong Loncom Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Shandong Loncom Pharmaceutical Lacosamide Drugs Product
Table 144. Shandong Loncom Pharmaceutical Recent Developments/Updates
Table 145. Jianmin Group Company Information
Table 146. Jianmin Group Description and Business Overview
Table 147. Jianmin Group Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Jianmin Group Lacosamide Drugs Product
Table 149. Jianmin Group Recent Developments/Updates
Table 150. Jiangxi Qingfeng Pharmaceutical Company Information
Table 151. Jiangxi Qingfeng Pharmaceutical Description and Business Overview
Table 152. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product
Table 154. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 155. Beijing Sihuan Pharmaceutical Company Information
Table 156. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 157. Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Beijing Sihuan Pharmaceutical Lacosamide Drugs Product
Table 159. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 160. Zhejiang Huahai Pharmaceutical Company Information
Table 161. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 162. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product
Table 164. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 165. Buchang Pharmaceutical Company Information
Table 166. Buchang Pharmaceutical Description and Business Overview
Table 167. Buchang Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Buchang Pharmaceutical Lacosamide Drugs Product
Table 169. Buchang Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Lacosamide Drugs Distributors List
Table 173. Lacosamide Drugs Customers List
Table 174. Lacosamide Drugs Market Trends
Table 175. Lacosamide Drugs Market Drivers
Table 176. Lacosamide Drugs Market Challenges
Table 177. Lacosamide Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lacosamide Drugs
Figure 2. Global Lacosamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lacosamide Drugs Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Injection Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Lacosamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Lacosamide Drugs Market Share by Application: 2023 & 2030
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Lacosamide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Lacosamide Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Lacosamide Drugs Sales (2019-2030) & (K Units)
Figure 15. Global Lacosamide Drugs Average Price (US$/Unit) & (2019-2030)
Figure 16. Lacosamide Drugs Report Years Considered
Figure 17. Lacosamide Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Lacosamide Drugs Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Lacosamide Drugs Players: Market Share by Revenue in Lacosamide Drugs in 2023
Figure 20. Lacosamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Lacosamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Lacosamide Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Lacosamide Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Lacosamide Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Lacosamide Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 43. Mexico Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Lacosamide Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Lacosamide Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Lacosamide Drugs by Type (2019-2030)
Figure 54. Global Lacosamide Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Lacosamide Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Lacosamide Drugs by Application (2019-2030)
Figure 57. Global Lacosamide Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. Lacosamide Drugs Value Chain
Figure 59. Lacosamide Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Lacosamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lacosamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Lacosamide Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lacosamide Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Lacosamide Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lacosamide Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lacosamide Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lacosamide Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lacosamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lacosamide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lacosamide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Lacosamide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lacosamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lacosamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lacosamide Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Lacosamide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Lacosamide Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Lacosamide Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Lacosamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lacosamide Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Lacosamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lacosamide Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lacosamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lacosamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lacosamide Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lacosamide Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Lacosamide Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Lacosamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lacosamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lacosamide Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Lacosamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Lacosamide Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Lacosamide Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Lacosamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Lacosamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lacosamide Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Lacosamide Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Lacosamide Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Lacosamide Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Lacosamide Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lacosamide Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lacosamide Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Lacosamide Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Lacosamide Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Lacosamide Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Lacosamide Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Lacosamide Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Lacosamide Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Lacosamide Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Lacosamide Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lacosamide Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lacosamide Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Lacosamide Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Lacosamide Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Lacosamide Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. UCB Pharma Company Information
Table 71. UCB Pharma Description and Business Overview
Table 72. UCB Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. UCB Pharma Lacosamide Drugs Product
Table 74. UCB Pharma Recent Developments/Updates
Table 75. Glenmark Pharmaceuticals Company Information
Table 76. Glenmark Pharmaceuticals Description and Business Overview
Table 77. Glenmark Pharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Glenmark Pharmaceuticals Lacosamide Drugs Product
Table 79. Glenmark Pharmaceuticals Recent Developments/Updates
Table 80. Camber Pharma Company Information
Table 81. Camber Pharma Description and Business Overview
Table 82. Camber Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Camber Pharma Lacosamide Drugs Product
Table 84. Camber Pharma Recent Developments/Updates
Table 85. Actavis Company Information
Table 86. Actavis Description and Business Overview
Table 87. Actavis Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Actavis Lacosamide Drugs Product
Table 89. Actavis Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sandoz Lacosamide Drugs Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Teva Lacosamide Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Apotex Company Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Apotex Lacosamide Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Mylan Lacosamide Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. Sun Pharma Company Information
Table 111. Sun Pharma Description and Business Overview
Table 112. Sun Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Sun Pharma Lacosamide Drugs Product
Table 114. Sun Pharma Recent Developments/Updates
Table 115. Aucta Pharma Company Information
Table 116. Aucta Pharma Description and Business Overview
Table 117. Aucta Pharma Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Aucta Pharma Lacosamide Drugs Product
Table 119. Aucta Pharma Recent Developments/Updates
Table 120. Hefei Yifan Biopharmaceuticals Company Information
Table 121. Hefei Yifan Biopharmaceuticals Description and Business Overview
Table 122. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product
Table 124. Hefei Yifan Biopharmaceuticals Recent Developments/Updates
Table 125. Jiangsu Haian Pharmaceutical Company Information
Table 126. Jiangsu Haian Pharmaceutical Description and Business Overview
Table 127. Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Jiangsu Haian Pharmaceutical Lacosamide Drugs Product
Table 129. Jiangsu Haian Pharmaceutical Recent Developments/Updates
Table 130. CSPC Ouyi Pharmaceutical Company Information
Table 131. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 132. CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. CSPC Ouyi Pharmaceutical Lacosamide Drugs Product
Table 134. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 135. Shijiazhuang No.4 Pharmaceutical Company Information
Table 136. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
Table 137. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product
Table 139. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
Table 140. Shandong Loncom Pharmaceutical Company Information
Table 141. Shandong Loncom Pharmaceutical Description and Business Overview
Table 142. Shandong Loncom Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Shandong Loncom Pharmaceutical Lacosamide Drugs Product
Table 144. Shandong Loncom Pharmaceutical Recent Developments/Updates
Table 145. Jianmin Group Company Information
Table 146. Jianmin Group Description and Business Overview
Table 147. Jianmin Group Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Jianmin Group Lacosamide Drugs Product
Table 149. Jianmin Group Recent Developments/Updates
Table 150. Jiangxi Qingfeng Pharmaceutical Company Information
Table 151. Jiangxi Qingfeng Pharmaceutical Description and Business Overview
Table 152. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product
Table 154. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 155. Beijing Sihuan Pharmaceutical Company Information
Table 156. Beijing Sihuan Pharmaceutical Description and Business Overview
Table 157. Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Beijing Sihuan Pharmaceutical Lacosamide Drugs Product
Table 159. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 160. Zhejiang Huahai Pharmaceutical Company Information
Table 161. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 162. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product
Table 164. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 165. Buchang Pharmaceutical Company Information
Table 166. Buchang Pharmaceutical Description and Business Overview
Table 167. Buchang Pharmaceutical Lacosamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Buchang Pharmaceutical Lacosamide Drugs Product
Table 169. Buchang Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Lacosamide Drugs Distributors List
Table 173. Lacosamide Drugs Customers List
Table 174. Lacosamide Drugs Market Trends
Table 175. Lacosamide Drugs Market Drivers
Table 176. Lacosamide Drugs Market Challenges
Table 177. Lacosamide Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lacosamide Drugs
Figure 2. Global Lacosamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lacosamide Drugs Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Injection Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Lacosamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Lacosamide Drugs Market Share by Application: 2023 & 2030
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Lacosamide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Lacosamide Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Lacosamide Drugs Sales (2019-2030) & (K Units)
Figure 15. Global Lacosamide Drugs Average Price (US$/Unit) & (2019-2030)
Figure 16. Lacosamide Drugs Report Years Considered
Figure 17. Lacosamide Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Lacosamide Drugs Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Lacosamide Drugs Players: Market Share by Revenue in Lacosamide Drugs in 2023
Figure 20. Lacosamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Lacosamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Lacosamide Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Lacosamide Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Lacosamide Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Lacosamide Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 43. Mexico Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Lacosamide Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Lacosamide Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Lacosamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Lacosamide Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Lacosamide Drugs by Type (2019-2030)
Figure 54. Global Lacosamide Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Lacosamide Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Lacosamide Drugs by Application (2019-2030)
Figure 57. Global Lacosamide Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. Lacosamide Drugs Value Chain
Figure 59. Lacosamide Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232